When analyzing the effect of Zeb1 ex vivo, the researchers found that its maximum effect on promoting CRC progression was achieved only upon co-expressing Dickkopf-related protein 1 (DKK1)—a Wnt protein antagonist that is transcriptionally activated by Zeb1 [80]. The gene discussed is ZEB1; the disease is colorectal carcinoma.